Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.

@article{Kobayashi2012HumanEN,
  title={Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.},
  author={Hironori Kobayashi and Yoshiaki Murakami and Kenichiro Uemura and Takeshi Sudo and Yasushi Hashimoto and Naru Kondo and Taijiro Sueda},
  journal={Annals of surgery},
  year={2012},
  volume={256 2},
  pages={288-96}
}
OBJECTIVE The aim of this study was to evaluate whether intratumoral human equilibrative nucleoside transporter 1 (hENT1) expression can predict the survival of advanced cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection. BACKGROUND There have been no reports concerning a useful predictive… CONTINUE READING